Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal nalbuphine with or without morphine for prevention of postoperative nausea and vomiting after laparoscopic liver resection
TCTR20260928003Phase 3Completed
- Sponsor
- N/A
- Start
- Sep 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine, morphine, bupivacaine in postoperative nausea and vomiting (PONV), sponsored by N/A. Started Sep 2024; status: completed.
02
Drugs
nalbuphinemorphinebupivacaine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on TCTR20260928003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260928003.